Literature DB >> 8977597

Effect of electrostatic charge, flow, delay and multiple actuations on the in vitro delivery of salbutamol from different small volume spacers for infants.

J H Wildhaber1, S G Devadason, E Eber, M J Hayden, M L Everard, Q A Summers, P N LeSouëf.   

Abstract

BACKGROUND: A study was undertaken to determine the influences of electrostatic charge, flow, delay, and multiple actuations on the in vitro delivery of salbutamol generated by a pressurised metered dose inhaler (pMDI) from small volume spacers used in infants.
METHODS: Ten actuations from a salbutamol pMDI were drawn at different flow rates after either single or multiple actuations, with or without delay, through either static or reduced static spacers. An ionic detergent was used to reduce the charge of plastic spacers (Babyhaler, Babyspacer, Aerochamber, Nebuhaler). Electrostatic charge was measured using an electrometer. A multistage liquid impinger was used to determine the particle size distribution of the output of the pMDI through the spacers.
RESULTS: Electrostatic charge on the surface of plastic spacers had the greatest influence on delivery, causing a decrease in drug delivery. Reducing charge by coating the surface with ionic detergent resulted in an increase of 46.5-71.1% (p < 0.001) in small (< 6.8 microns) particle delivery from small volume plastic spacers. Lower flow, delay, and multiple actuations resulted in decreased delivery from static spacers. Lower flow resulted in a decrease of 15% in small (< 9.6 microns) particle delivery. Delay and multiple actuations resulted in a decrease of 40.7% and 76.0%, respectively, in small (< 6.8 microns) particle delivery. The influences of lower flow, delay, and multiple actuations were greatly reduced or even eliminated by reducing charge. However, multiple actuations still resulted in a significant decreased delivery (p < 0.05). The reduced static Nebuhaler had a higher delivery than all small volume spacers.
CONCLUSIONS: Electrostatic charge has a major influence on the delivery of salbutamol from small volume spacers. Using a metal spacer or ionic detergent coating of plastic spacers resulted in no or reduced charge and hence in improved delivery. Lower flow, delay, and multiple actuations played a major part only in static spacers.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8977597      PMCID: PMC472645          DOI: 10.1136/thx.51.10.985

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  13 in total

1.  Drug delivery from holding chambers with attached facemask.

Authors:  M L Everard; A R Clark; A D Milner
Journal:  Arch Dis Child       Date:  1992-05       Impact factor: 3.791

2.  A new baby-spacer device for aerosolized bronchodilator administration in infants with bronchopulmonary disease.

Authors:  R Kraemer; P Birrer; K Modelska; C C Aebischer; M H Schöni
Journal:  Eur J Pediatr       Date:  1992-01       Impact factor: 3.183

3.  Oropharyngeal deposition and delivery aspects of metered-dose inhaler aerosols.

Authors:  C S Kim; M A Eldridge; M A Sackner
Journal:  Am Rev Respir Dis       Date:  1987-01

4.  Spacing devices and metered-dose inhalers in childhood asthma.

Authors:  H Levison; P A Reilly; G H Worsley
Journal:  J Pediatr       Date:  1985-11       Impact factor: 4.406

5.  The effect of delay, multiple actuations and spacer static charge on the in vitro delivery of budesonide from the Nebuhaler.

Authors:  P W Barry; C O'Callaghan
Journal:  Br J Clin Pharmacol       Date:  1995-07       Impact factor: 4.335

6.  Inhalation anti-asthma therapy with spacers: technical aspects.

Authors:  P Zanon
Journal:  Monaldi Arch Chest Dis       Date:  1994-06

7.  Multiple actuations of salbutamol MDI into a spacer device reduce the amount of drug recovered in the respirable range.

Authors:  P W Barry; C O'Callaghan
Journal:  Eur Respir J       Date:  1994-09       Impact factor: 16.671

Review 8.  Spacer devices used with metered-dose inhalers. Breakthrough or gimmick?

Authors:  P König
Journal:  Chest       Date:  1985-08       Impact factor: 9.410

9.  Delivery of beclomethasone dipropionate from a spacer device: what dose is available for inhalation?

Authors:  C O'Callaghan; M Cant; C Robertson
Journal:  Thorax       Date:  1994-10       Impact factor: 9.139

10.  Short-term effect of albuterol, delivered via a new auxiliary device, in wheezy infants.

Authors:  R Kraemer; U Frey; C W Sommer; E Russi
Journal:  Am Rev Respir Dis       Date:  1991-08
View more
  25 in total

1.  Randomised controlled study of clinical efficacy of spacer therapy in asthma with regard to electrostatic charge.

Authors:  E Dompeling; A M Oudesluys-Murphy; H M Janssens; W Hop; J G Brinkman; R N Sukhai; J C de Jongste
Journal:  Arch Dis Child       Date:  2001-02       Impact factor: 3.791

2.  Reducing electrostatic charge on spacer devices and bronchodilator response.

Authors:  J H Wildhaber; G W Waterer; G L Hall; Q A Summers
Journal:  Br J Clin Pharmacol       Date:  2000-09       Impact factor: 4.335

3.  Lung deposition of aerosol--a comparison of different spacers.

Authors:  H J Zar; E G Weinberg; H J Binns; F Gallie; M D Mann
Journal:  Arch Dis Child       Date:  2000-06       Impact factor: 3.791

4.  Funhaler spacer: improving adherence without compromising delivery.

Authors:  P M Watt; B Clements; S G Devadason; G M Chaney
Journal:  Arch Dis Child       Date:  2003-07       Impact factor: 3.791

5.  Aerosol profile extracted from spacers as a determinant of actual dose.

Authors:  Sylvia Verbanck; Chris Vervaet; Daniël Schuermans; Walter Vincken
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

Review 6.  Aerosol delivery to ventilated newborn infants: historical challenges and new directions.

Authors:  Jan Mazela; Richard A Polin
Journal:  Eur J Pediatr       Date:  2010-09-28       Impact factor: 3.183

Review 7.  A path to successful patient outcomes through aerosol drug delivery to children: a narrative review.

Authors:  Arzu Ari
Journal:  Ann Transl Med       Date:  2021-04

8.  The interaction between the oropharyngeal geometry and aerosols via pressurised metered dose inhalers.

Authors:  T Ehtezazi; I Saleem; I Shrubb; D R Allanson; I D Jenkinson; C O'Callaghan
Journal:  Pharm Res       Date:  2009-11-10       Impact factor: 4.200

Review 9.  Aerosol therapy for obstructive lung diseases: device selection and practice management issues.

Authors:  Michael W Sims
Journal:  Chest       Date:  2011-09       Impact factor: 9.410

10.  Lung delivery of non-CFC salbutamol via small volume metal spacer and large volume plastic spacer devices compared with an open vent jet nebulizer.

Authors:  B J Lipworth; D J Clark
Journal:  Br J Clin Pharmacol       Date:  1998-02       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.